Literature DB >> 16406349

Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity.

Anna Maria Paoletti1, Sandra Romagnino, Rossana Contu, Marisa Margherita Orrù, Maria Francesca Marotto, Pierina Zedda, Stefano Lello, Giovanni Biggio, Alessandra Concas, Gian Benedetto Melis.   

Abstract

We investigated whether pregnancy could modify psychological symptoms and whether neuroactive steroids which exert an anti-anxiety effect by acting on the gamma-aminobutyric acid (GABA)-A receptors, are modified during pregnancy in young healthy women. Healthy volunteer women in the Department of Obstetrics and Gynecology at Cagliari University participated in the study. They were divided into women with low (group 1, seven subjects) and high (group 2, seven subjects) psychological score by SCL-90 psychometric scale. Age, body mass index and physiological status of pregnancy did not differ between the groups. The subjects were studied before pregnancy during the follicular phase (FP), and the luteal phase (LP) of the menstrual cycle (MC) and four times during pregnancy (at 14th, 22nd, 30th, and 38th week). SCL-90 psychometric scale, circulating levels of progesterone (P4), 3alpha-hydroxy-5alpha-pregnan-20-one (allopregnanolone, AP), 3alpha,21-dihydroxy-5alpha-pregnan-20-one (allotetrahydrodeoxy-corticosterone, THDOC), cortisol and DHEAS were assayed at each visit. The SCL-90 global score and the intensity of psychological symptoms differ between the groups, but within each group they did not change both during MC and during pregnancy. The DHEAS and cortisol levels did not differ between the groups. DHEAS did not change during the study, whereas cortisol levels increased during pregnancy in both groups. Progesterone, AP, and THDOC levels were higher during LP than during FP and further increased during pregnancy, without any difference between the groups. In conclusion, pregnancy does not seem to interfere with the psychological status of healthy women independently of the psychological basal score. Some neuroactive steroids with anxiolytic activity seem to increase during pregnancy depending on placental function. Their increase could represent some kind of protection against maternal anxiety and stress due to concerns about the pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406349     DOI: 10.1016/j.psyneuen.2005.11.006

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  13 in total

Review 1.  Stress, ethanol, and neuroactive steroids.

Authors:  Giovanni Biggio; Alessandra Concas; Paolo Follesa; Enrico Sanna; Mariangela Serra
Journal:  Pharmacol Ther       Date:  2007-05-08       Impact factor: 12.310

2.  Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test.

Authors:  Cheryl A Frye
Journal:  J Psychopharmacol       Date:  2009-12-04       Impact factor: 4.153

3.  Juvenile social isolation affects maternal care in rats: involvement of allopregnanolone.

Authors:  Maria Giuseppina Pisu; Giorgia Boero; Francesca Biggio; Anna Garau; Daniela Corda; Mauro Congiu; Alessandra Concas; Patrizia Porcu; Mariangela Serra
Journal:  Psychopharmacology (Berl)       Date:  2017-06-16       Impact factor: 4.530

Review 4.  Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.

Authors:  Chase Matthew Carver; Doodipala Samba Reddy
Journal:  Psychopharmacology (Berl)       Date:  2013-09-27       Impact factor: 4.530

5.  The impact of thyroidectomy on psychiatric symptoms and quality of life.

Authors:  P Miccoli; M N Minuto; R Paggini; P Rucci; A Oppo; G Donatini; F Golia; L Novelli; M Carlini; L Dell'Osso
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

6.  Time-dependent modulation of GABA(A)-ergic synaptic transmission by allopregnanolone in locus coeruleus neurons of Mecp2-null mice.

Authors:  Xin Jin; Weiwei Zhong; Chun Jiang
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-25       Impact factor: 4.249

Review 7.  Neurosteroid regulation of GABA(A) receptors: Focus on the alpha4 and delta subunits.

Authors:  Sheryl S Smith; Hui Shen; Qi Hua Gong; Xiangping Zhou
Journal:  Pharmacol Ther       Date:  2007-04-21       Impact factor: 12.310

8.  Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.

Authors:  Stephen J Kanes; Helen Colquhoun; James Doherty; Shane Raines; Ethan Hoffmann; David R Rubinow; Samantha Meltzer-Brody
Journal:  Hum Psychopharmacol       Date:  2017-03       Impact factor: 1.672

Review 9.  Allopregnanolone in postpartum depression: Role in pathophysiology and treatment.

Authors:  Samantha Meltzer-Brody; Stephen J Kanes
Journal:  Neurobiol Stress       Date:  2020-02-03

Review 10.  Plasticity of GABAA Receptors during Pregnancy and Postpartum Period: From Gene to Function.

Authors:  Valentina Licheri; Giuseppe Talani; Ashish A Gorule; Maria Cristina Mostallino; Giovanni Biggio; Enrico Sanna
Journal:  Neural Plast       Date:  2015-08-30       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.